comparemela.com


Aptose Expands Senior Leadership Team
Aptose Biosciences Inc. a clinical stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today announced the appointment of two key members to its management team to support the company’s expanding clinical CMC and regulatory functions: George P. Melko, Pharm.D., joins Aptose as Vice President, Regulatory Affairs; and Robert B. Killion Jr., Ph.D. has been …
George Melko, Pharm.D. joins as Vice President, Regulatory Affairs
Robert Killion, Ph.D. appointed Vice President, CMC
Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today announced the appointment of two key members to its management team to support the company’s expanding clinical CMC and regulatory functions: George P. Melko, Pharm.D., joins Aptose as Vice President, Regulatory Affairs; and Robert B. Killion Jr., Ph.D. has been named Vice President, CMC.

Related Keywords

United States ,Georgep Melko ,Aptose Biosciences ,Robertb Killion Jr ,Poulenc Rorer ,Robert Killion ,Susan Pietropaolo ,Greg Chow ,George Melko ,Genentech ,Lifesci Advisors ,Regulatory Affairs ,Astrazeneca Pharmaceuticals ,Aptose Biosciences Inc ,Nasdaq ,European Medicines Agency ,Incyte Corporation ,Vice President ,Tmunity Therapeutics ,Tessa Therapeutics ,Investigational New Drug ,Senior Director ,Chief Executive ,Sci Advisors ,Managing Director ,ஒன்றுபட்டது மாநிலங்களில் ,ராபர்ட் கிலியந் ,கிரெக் சோவ் ,ஜெநிஂடெக் ,ஒழுங்குமுறை வாழ்க்கைத்தொழில்கள் ,நாஸ்டாக் ,துணை ப்ரெஸிடெஂட் ,டெஸ்ஸா சிகிச்சை ,மூத்தவர் இயக்குனர் ,தலைமை நிர்வாகி ,நிர்வகித்தல் இயக்குனர் ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.